Vikas Gupta

Dr. Gupta's scholarly work is focused on advancing transplant and non-transplant strategies for the treatment of patients with myeloid malignancies, in particular BCR-ABL negative myeloproliferative neoplasms (MPN). These conditions are rare and available treatments are modestly effective at best. Dr. Gupta has led multi-centre, international clinical trials and observational cohort studies through partnerships he has developed with the Myeloproliferative Disease Research Consortium in New York, which is funded by the US National Cancer Institute, and the Centre for International Blood and Bone Marrow Transplant Research. He has established a unique MPN Program at the Princess Margaret Cancer Centre, which serves as a national resource for the care of complex MPN patients and for Multi-disciplinary basic translational and clinical research in MPN. As a result, the program attracts clinical and research fellows from around the world.